Track topics on Twitter Track topics that are important to you
SAN JOSE, Calif., July 21, 2015 (GLOBE NEWSWIRE) -- Firsthand Technology Value Fund, Inc. (NASDAQ:SVVC) (the "Fund"), a publicly-traded venture capital fund that invests in technology and cleantech companies, disclosed today that its preliminary NAV as of June 30, 2015 was $24.54 per share. The Fund also announced that its top five holdings as of that date were IntraOp Medical, Pivotal, Turn, QMAT, and Wrightspeed.
1. IntraOp Medical, Inc. is the manufacturer of the Mobetron, a medical device that is used to deliver intra-operative radiation to cancer patients. As of June 30, 2015, the Fund's investment in IntraOp consisted of 23,300,000 shares of preferred stock plus debt securities and represented approximately 12.6% of the Fund's preliminary net assets.
2. Pivotal Systems, Inc. provides monitoring and process control technologies for the semiconductor manufacturing industry. As of June 30, 2015, the Fund's investment in Pivotal consisted of 22,148,288 shares of preferred stock plus debt securities, and represented approximately 10.9% of the Fund's preliminary net assets.
3. Turn Inc. is a leading provider of advertising technology to Fortune 1000 marketers and their agencies. As of June 30, 2015, the Fund's investment in Turn consisted of 1,798,562 shares of preferred stock and represented approximately 8.0% of the Fund's preliminary net assets.
4. QMAT, Inc. is developing advanced materials technologies for applications in the electronics industry. As of June 30, 2015, the Fund's investment in QMAT consisted of 12,000,240 shares of preferred stock plus warrants to purchase additional shares, and represented approximately 6.3% of the Fund's preliminary net assets.
5. Wrightspeed, Inc. is a supplier of electric drivetrains for medium-duty trucks. As of June 30, 2015, the Fund's investment in Wrightspeed consisted of 3,368,637 shares of preferred stock, and represented approximately 5.9% of the Fund's preliminary net assets.
The Fund's preliminary net assets as of June 30, 2015 also include cash of approximately $0.47 per share. As of that date, the Fund's top five holdings constituted 43.7% of the Fund's preliminary net assets. Complete financial statements and a detailed schedule of investments will be made available with the Fund's quarterly report filing on Form 10-Q in August 2015.
About Firsthand Technology Value Fund
Firsthand Technology Value Fund, Inc. is a publicly traded venture capital fund that invests in technology and cleantech companies. More information about the Fund and its holdings can be found online at www.firsthandtvf.com.
The Fund is a non-diversified, closed-end investment company that elected to be treated as a business development company under the Investment Company Act of 1940. The Fund's investment objective is to seek long-term growth of capital. Under normal circumstances, the Fund will invest at least 80% of its total assets for investment purposes in technology and cleantech companies. An investment in the Fund involves substantial risks, some of which are highlighted below. Please see the Fund's public filings for more information about fees, expenses and risk. Past investment results do not provide any assurances about future results.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release contains "forward-looking statements" as defined under the U.S. federal securities laws. Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will," and similar expressions identify forward-looking statements, which generally are not historical in nature. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to materially differ from the Fund's historical experience and its present expectations or projections indicated in any forward-looking statement. These risks include, but are not limited to, changes in economic and political conditions, regulatory and legal changes, technology and cleantech industry risk, valuation risk, non-diversification risk, interest rate risk, tax risk, and other risks discussed in the Fund's filings with the SEC. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. The Fund undertakes no obligation to publicly update or revise any forward-looking statements made herein. There is no assurance that the Fund's investment objectives will be attained. We acknowledge that, notwithstanding the foregoing, the safe harbor for forward-looking statements under the Private Securities Litigation Reform Act of 1995 does not apply to investment companies such as us.
CONTACT: Heather Hohlowski Firsthand Capital Management, Inc. (408) 624-9525 firstname.lastname@example.orgNEXT ARTICLE
The role of medical devices in healthcare is essential. The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare. Covering a wide range of products, from simple bandages to the...
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...